Clinical and laboratory characteristics of human immunodeficiency virus-infected adolescents: Experience from a single medical center

Journal of Microbiology, Immunology and Infection

Volumn 45, Issue 5, 2012, Pages 329-336

  Lee, Kuan Hsien ^a   Ho, Tzong Shiann ^a,b   Shen, Ching Fen ^a   Wang, Shih Min ^a,b   Ko, Wen Chien ^a   Liu, Ching Chuan ^a,b  

^a NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

Adolescents; Human immunodeficiency virus; Seroprevalence; Sexually transmitted disease

Indexed keywords

ANTIRETROVIRUS AGENT; HEPATITIS A ANTIBODY; HEPATITIS ANTIBODY; HEPATITIS B SURFACE ANTIGEN;

ADOLESCENT; ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CLINICAL ARTICLE; CONDYLOMA ACUMINATUM; CONTROLLED STUDY; EXPERIENCE; FEMALE; FOLLOW UP; HETEROSEXUALITY; HIGH RISK POPULATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INTRAVENOUS DRUG ABUSE; MALE; MALE HOMOSEXUAL; MEDICAL CARE; MEDICAL RECORD; MEDICAL RECORD REVIEW; PREVALENCE; SEXUALLY TRANSMITTED DISEASE; SYPHILIS; TAIWAN; UNIVERSITY HOSPITAL; VIRUS LOAD;

ADOLESCENT; CD4 LYMPHOCYTE COUNT; CONDYLOMATA ACUMINATA; FEMALE; HEPATITIS A ANTIBODIES; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS C ANTIBODIES; HIV; HIV INFECTIONS; HOMOSEXUALITY, MALE; HOSPITALS, UNIVERSITY; HUMANS; MALE; RISK FACTORS; TAIWAN; VIRAL LOAD; YOUNG ADULT;

EID: 84866619019     PISSN: 16841182     EISSN: 19959133     Source Type: Journal    
DOI: 10.1016/j.jmii.2011.12.010     Document Type: Article

References (29)

1. The United Nations Joint programme on HIV/AIDS. AIDS epidemic update: December 2009. Available from: [accessed on 5.12.10]. http://www.unaids.org/en/media/unaids/contentassets/dataimport/pub/report/2009/jc1700_epi_update_2009_en.pdf.
2. Centers for Disease Control and Prevention HIV/AIDS surveillance report 1994, 6. Centers for Disease Control and Prevention. U.S. Dept of Health and Human Services, Atlanta, GA, p. 33.
3. Centers for Disease Control and Prevention HIV/AIDS surveillance report 2008, 17. Centers for Disease Control and Prevention. U.S. Dept of Health and Human Services, Atlanta, GA, p. 1.
4. Gavin L., MacKay A.P., Brown K., Harrier S., Ventura S.J., Kann L. Sexual and reportable health of persons age 10-24 years - United States, 2002-2007. MMWR surveill Summ 2009, 58:1-58.
5. Yeh C.H. Sexual risk taking among Taiwanese youth. Public Health Nurs 2002, 19:68-75.
6. Lin H.S. Taiwanese student sexual knowledge, Attitude and Behavior survey 2000, Bureau of Health Promotion. Department of Health, Taiwan, R.O.C.
7. HsiehYH High risk sexual behavious and genital Chlamydia infections in high school students in Southern Taiwan. Int J STD AIDS 2010, 21:253-259.
8. Press release from AIDS Virtual Museum of CDC Taiwan on Dec 01, 2010. Available from: [accessed 30.12.10]. http://www.cdc.gov.tw/lp.asp?CtNode=1069&CtUnit=185&BaseDSD=7&mp=220&nowPage=2&pagesize=15.
9. Taiwan Government's Responses to HIV/AIDA. Dec 7, 2007. Available from: [assessed 1.12.10]. http://www.cdc.gov.tw/content.asp?CuItem=7424.
10. World Health Organization. WHO case definitions of HIV for surveillance and revised clinical staging and immunological classification of HIV-related disease in adults and children. 2006. Available from: [accessed 10.12.10]. http://www.who.int/hiv/pub/guidelines/en/.
11. World Health Organization. PMTCT Strategic Vision 2010--2015. Preventing mother-to-child transmission of HIV to reach the UNGASS and Millennium Development Goals. Feb 2, 2010. Available from: [accessed 5.12.10]. http://www.who.int/hiv/pub/mtct/strategic_vision.pdf.
12. Notifiable Infectious Disease Statistics System of CDC Taiwan Avaiable from: [assessed 02.01.11]. http://nidss.cdc.gov.tw/SingleDisease.aspx?dc=1&dt=3&disease=044.
13. Morgan D., Mahe C., Mayanja B., Okongo J.M., Lubega R., Whitworth J.A. HIV-1 infection in rural Africa: is there a difference in median time to AIDS and survival compared with that in industrialized countries?. AIDS 2002, 16:597-603.
14. Dean M., Carrington M., Winkler C., Huttley G.A., Smith M.W., Allikmets R., et al. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia growth and development study, multicenter AIDS cohort study, multicenter hemophilia cohort study, San Francisco city cohort, ALIVE study. Science 1996, 273:1856-1862.
15. Sun H.Y., Kung H.C., Ho Y.C., Chien Y.F., Chen M.Y., Sheng W.H., et al. Seroprevalence of hepatitis A virus infection in persons with HIV infection in Taiwan: implications for hepatitis A vaccination. Int J Infect Dis 2009, 13:e199-e205.
16. Aberg J.A., Kaplan J.E., Libman H., Emmanuel P., Anderson J.R., Stone V.E., et al. Primary care guidelines for the management of persons infected with human immunodeficiency virus: 2009 update by the HIV medicine Association of the Infectious Diseases Society of America. Clin Infect Dis 2009, 49:651-681.
17. Crum-Cianflone N.F., Wilkins K., Lee A.W., Grosso A., Landrum M.L., Weintrob A., et al. Long-term durability of immune responses after hepatitis A vaccination among HIV-infected adults. J Infect Dis 2011, 203:1815-1823.
18. Saksawad R., Likitnukul S., Warachit B., Hanvivatvong O., Poovorawan Y., Puripokai P. Immunogenicity and safety of a pediatric dose virosomal hepatitis A vaccine in Thai HIV-infected children. Vaccine 2011, 29:4735-4738.
19. Ni Y.H., Huang L.M., Chang M.H., Yen C.J., Lu C.Y., You S.L., et al. Two decades of universal hepatitis B vaccination in Taiwan: impact and implication for future strategies. Gastroenterology 2007, 132:1287-1293.
20. Sun H.Y., Ko W.C., Tsai J.J., Lee H.C., Liu C.E., Wong W.W., et al. Seroprevalence of chronic hepatitis B virus infection among taiwanese human immunodeficiency virus type 1-positive persons in the era of nationwide hepatitis B vaccination. Am J Gastroenterol 2009, 104:877-884.
21. Lu C.Y., Ni Y.H., Chiang B.L., Chen P.J., Chang M.H., Chang L.Y., et al. Humoral and cellular immune responses to a hepatitis B vaccine booster 15-18 years after neonatal immunization. J Infect Dis 2008, 197:1419-1426.
22. Lee H.C., Ko N.Y., Lee N.Y., Chang C.M., Liu S.Y., Ko W.C. Trends in sexually transmitted diseases and risky behaviors among HIV-infected patients at an outpatient clinic in Southern Taiwan. Sex Transm Dis 2010, 37:86-92.
23. Alan Nyitray G., Carvalho da Silva R.J., Baggio M.L., Lu B., Smith D., Abrahamsen M., et al. Age-Specific prevalence of and risk factors for anal Human Papillomavirus (HPV) among men who had sex with women and men who have sex with men: the HPV in Men (HIM) Study. J Infect Dis 2011, 203:49-57.
24. Goldstone S., Palefsky J.M., Giuliano A.R., Moreira E.D., Aranda C., Jessen H., et al. Prevalence of and risk factors for Human Papillomavirus (HPV) infection among HIV-negative men who have sex with men. J Infect Dis 2011, 203:66-74.
25. Dolev J.C., Maurer T., Springer G., Glesby M.J., Minkoff H., Connell C. Incidence and risk factors for verrucae in women. AIDS 2008, 22:1213-1219.
26. Murphy D.A., Wilson C.M., Durako S.J., Muenz L.R., Belzer M. Adolescent medicine HIV/AIDS research network. Antiretroviral medication adherence among the REACH HIV-infected adolescent cohort in the USA. AIDS care 2001, 13:27-40.
27. Reisner S.L., Mimiaga M.J., Skeer M., Perkovich B., Johnson C.V., Safren S.A. A review of HIV antiretroviral adherence and intervention studies among HIV-infected youth. Top HIV Med 2009, 17:14-25.
28. Johnson B.T., Scott-Sheldon L.A., Huedo-Medina T.B., Carey M.P. Interventions to Reduce Sexual Risk for Human Immunodeficiency Virus, 1985-2008. Arch Pediatr Adolesc Med 2011, 165:77-84.
29. Marks G., Crepaz N., Senterfitt J.W., Janssen R.S. Meta-analysis of high-risk sexual behavior in persons aware and unaware they are infected with HIV in the United States: implications for HIV prevention programs. J Acquir Immune Defic Syndr 2005, 39:446-453.